Your browser doesn't support javascript.
loading
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107).
Amadori, Sergio; Stasi, Roberto; Martelli, Alberto M; Venditti, Adriano; Meloni, Giovanna; Pane, Fabrizio; Martinelli, Giovanni; Lunghi, Monia; Pagano, Livio; Cilloni, Daniela; Rossetti, Elena; Di Raimondo, Francesco; Fozza, Claudio; Annino, Luciana; Chiarini, Francesca; Ricci, Francesca; Ammatuna, Emanuele; La Sala, Edoardo; Fazi, Paola; Vignetti, Marco.
Affiliation
  • Amadori S; Department of Haematology, Tor Vergata University Hospital, Roma, Italy Department of Haematology, St. George's Hospital, London, UK. sergio.amadori@ptvonline.it
Br J Haematol ; 156(2): 205-12, 2012 Jan.
Article in En | MEDLINE | ID: mdl-22082314
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Salvage Therapy Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2012 Type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Salvage Therapy Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2012 Type: Article Affiliation country: United kingdom